Main Article Content

Authors

Introduction: Spontaneous rectus sheath hematoma (SRSH) is a rare and potentially fatal event; the literature describes anticoagulation as the main risk factor, especially with the use of warfarin. Few cases have been reported with the use of direct oral anticoagulants (DOAC) and most of them report another associated precipitating factor. We present a case of SRSH associated with the use of DOACs in which no other precipitating factor other than anticoagulation was identified.


Case presentation: 74-year-old woman who consulted at an IV level hospital in Bogotá due to abdominal pain and a palpable mass of sudden onset not associated with trauma. She had a history of recurrent venous thromboembolic disease for which she had been anticoagulated with rivaroxaban. Physical examination revealed a painful mass on the left flank, without peritoneal irritation. Angiotomography of abdominal vessels was performed, which showed a hematoma of the left rectus abdominis muscle with active bleeding from the inferior epigastric artery. No other related factors other than anticoagulation were found as a possible etiology. Selective arterial embolization was performed with adequate bleeding control, which allowed early resumption of anticoagulation.


Discussion: SRSH is a potentially fatal entity, anticoagulation is reported as the main associated factor, although it is an infrequent event with DOACs. Most of them also describe triggering factors such as coughing, straining, and vomiting and will require expectant management, however, early endovascular management should be considered for better outcomes.


Key words: hematoma, abdominal wall, anticoagulants, rivaroxaban, case report

Sandra Brigitte Amado Garzon, Pontificia Universidad javeriana

Medico especialista en Medicina Interna . Magistra en Epidemiologia clinica . Profesor asistente Pontificia Universidad Javeriana Bogota Colombia

Paula Andrea Ruiz Talero, Hospital Universitario San Ignacio

Medico especialista en Medicina Interna 

Coordinador clinica de anticoagulacion y programa libre de Trombosis Hospital San Ignacio

Profesor A Honorem Universidad Javeriana Bogota Colombia 

Maria Natalia Serrano , Hospital Universitario San Ignacio

Medico Internista 

Amado Garzon, S. B., Ruiz Talero, P. A., & Serrano , M. N. . (2024). Spontaneous Abdominal Wall Hematoma Associated with the Use of Direct-Acting Oral Anticoagulants: a Case Report. Revista Ciencias De La Salud, 22(3), 1–8. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.12780

Budnitz DS, Shehab N, Lovegrove MC, Geller AI, Lind JN, Pollock DA. US Emergency department visits attributed to medication harms, 2017-2019. JAMA. 2021 Oct 5;326(13):1299-1309. https://doi.org/10.1001/jama.2021.13844

Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med. 1993 Sep;95(3):315-28. https://doi.org/10.1016/0002-9343(93)90285-w

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009 Sep 17;361(12):1139-51. https://doi.org/10.1056/NEJMoa0905561

Granger CB, Alexander JH, McMurray JJV, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15;365(11):981-92. https://doi.org/10.1056/NEJMoa1107039

Cherry WB, Mueller PS. Rectus sheath hematoma. Medicine. 2006 Mar;85(2):105-10.

Smithson A, Ruiz J, Perello R, Valverde M, Ramos J, Garzo L. Diagnostic and management of spontaneous rectus sheath hematoma. Eur J Intern Med. 2013 Sep;24(6):579-82. https://doi.org/10.1016/j.ejim.2013.02.016

Sheth HS, Kumar R, DiNella J, Janov C, Kaldas H, Smith RE. Evaluation of risk factors for rectus sheath hematoma. Clin Appl Thromb Hemost. 2016 Apr 7;22(3):292-6. https://doi.org/10.1177/1076029614553024

Kasotakis G. Retroperitoneal and rectus sheath hematomas. Surg Clin N Am. 2014 Feb;94(1):71-6.

Warren MH, Bhattacharya B, Maung AA, Davis KA. Contemporary management of spontaneous retroperitoneal and rectus sheath hematomas. Am J Surg. 2020 Apr;219(4):707-10. https://doi.org/10.1016/j.amjsurg.2019.05.002

Berná JD, Zuazu I, Madrigal M, García-Medina V, Fernández C, Guirado F. Conservative treatment of large rectus sheath hematoma in patients undergoing anticoagulant therapy. Abdom Imaging. 2000 May 1;25(3):230-4. https://doi.org/10.1007/s002610000007

Berná JD, Garcia-Medina V, Guirao J, Garcia-Medina J. Rectus sheath hematoma: diagnostic classification by CT. Abdom Imaging. 1996 Jan 1;21(1):62-4. https://doi.org/10.1007/s002619900011

Talari G, Talari P, Sweigart J, Ahmed S. Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy. BMJ Case Rep. 2016 Dec 23;bcr2016217801.

Elango K, Murthi S, Devasahayam J, Gunasekaran K. Spontaneous rectus sheath haematoma due to cough on apixaban. BMJ Case Rep. 2018 Apr 11;bcr-2018-225136. https://doi.org/10.1136/bcr-2018-225136

Börekci E. Rectus sheath hematoma and retroperitoneal bleeding due to rivaroxaban: a case report. Afr Health Sci. 2019 Aug 21;19(2):2290-3. https://doi.org/10.4314/ahs.v19i2.55

Karapolat B, Tasdelen HA, Korkmaz HAA. Conservative treatment of spontaneous rectus sheath hematomas: single center experience and literature review. Emerg Med Int. 2019 Feb 21;2019:1-7. https://doi.org/10.1155/2019/2406873

Downloads

Download data is not yet available.